Expanding the Phenotypic and Functional Evidence for KCNK3 as a Neurodevelopmental Disorder Gene: A New Chinese Case and Drosophila Validation
Clinical Genetics · 2026
DOI: 10.1111/cge.70216 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Genetics, 2026. Verfasst von Yuanyuan Sun und 12 weiteren Autor:innen. Beteiligte Einrichtung: Clinical School of Pediatrics, Tianjin Medical University, Tianjin, China. Hauptthemen laut MEDLINE: Potassium Channels, Tandem Pore Domain, Neurodevelopmental Disorders, Genetic Predisposition to Disease. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Tianjin Municipal Education Commission.
Abstract (Originalsprache)
Neurodevelopmental disorders (NDDs) are a group of developmental brain disorders caused by various genetic or acquired factors. OMIM has only recently associated the KCNK3 gene with developmental delay associated with sleep apnea (DDSA). Most prior studies on the KCNK3 gene have focused on PAH and cardiovascular diseases. In a 2‐year‐old girl presenting with generalized hypotonia and delayed language development, we identified a de novo missense variant in KCNK3 through the reanalysis of trio‐whole exome sequencing (trio‐WES) data. To further explore the relationship between KCNK3 and neurodevelopmental phenotypes, we conducted bidirectional expression regulation of the homologous gene Task7 based on the Drosophila model. Both overexpression and knockdown of the Task7 gene induced anxiety‐like behaviors and impaired learning and memory. Notably, Task7 overexpression also led to reduced climbing ability and abnormal sleep patterns; collectively, these four phenotypes recapitulate the characteristic hallmarks of human neurodevelopmental disorders. This study represents the first application of a Drosophila model to demonstrate that KCNK3 functions as a dosage‐sensitive regulator of neurodevelopment. While the underlying mechanisms remain to be fully elucidated, these findings position KCNK3 as a candidate gene for molecular screening and pave the way for future functional studies and therapeutic exploration in NDDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical School of Pediatrics, Tianjin Medical University, Tianjin, China.
- Children's Hospital, Tianjin University, Tianjin, China.
- Tianjin Pediatric Research Institute, Tianjin, China.
- Tianjin Key Laboratory of Birth Defects for Prevention and Treatment, Tianjin, China.
- National Children's Regional Medical Center, Tianjin, China.
- Department of Neurology, Tianjin Children's Hospital, Tianjin, China.
ORCID-Profile: Jianbo Shu, Chunquan Cai
Förderung
- Tianjin Municipal Education Commission
Zitieren
APA
Sun, Y., Wang, L., Zhang, L., Gu, C., Zhai, C., Wang, H., Chen, J., Liu, X., Ma, X., Zhang, S., Li, D., Shu, J., & Cai, C. (2026). Expanding the Phenotypic and Functional Evidence for KCNK3 as a Neurodevelopmental Disorder Gene: A New Chinese Case and Drosophila Validation. Clinical Genetics. https://doi.org/10.1111/cge.70216
Vancouver
Sun Y, Wang L, Zhang L, Gu C, Zhai C, Wang H, et al. Expanding the Phenotypic and Functional Evidence for KCNK3 as a Neurodevelopmental Disorder Gene: A New Chinese Case and Drosophila Validation. Clinical Genetics. 2026. doi:10.1111/cge.70216
BibTeX
@article{Sun2026,
author = {Sun, Yuanyuan and Wang, Leyi and Zhang, Liwei and Gu, Chunyu and Zhai, Chaojun and Wang, Hong and Chen, Jing and Liu, Xiaoyu and Ma, Ximeng and Zhang, Shuyue and Li, Dong and Shu, Jianbo and Cai, Chunquan},
title = {Expanding the Phenotypic and Functional Evidence for KCNK3 as a Neurodevelopmental Disorder Gene: A New Chinese Case and Drosophila Validation},
journal = {Clinical Genetics},
year = {2026},
doi = {10.1111/cge.70216}
}
EUVIMED